Acute Rejection Risk in Kidney Transplant Recipients on Steroid-Avoidance Immunosuppression Receiving Induction With Either Antithymocyte Globulin or Basiliximab

Autor: Heilman, R.L., Reddy, K.S., Mazur, M.J., Moss, A.A., Post, D.J., Petrides, S., Mulligan, D.C.
Zdroj: In Transplantation Proceedings 2006 38(5):1307-1313
Databáze: ScienceDirect